To access this element change to forms mode OFF
Grant Award View - GA80741-V1
Commercialisation of single-dose biopolymer vaccine delivery platform
GA ID:
GA80741-V1
Agency:
Department of Industry, Science and Resources
Approval Date:
9-Apr-2020
Variation Publish Date:
3-Aug-2021
Variation Date:
3-Aug-2021
Category:
Business Development
Grant Term:
29-May-2020 to 5-Mar-2026
Value (AUD):
$165,000.00
(GST inclusive where applicable)
Varies:
GA80741
- Commercialisation of single-dose biopolymer vaccine delivery platform
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DISR 19/20 Growing innovative & competitive bus, industries & regions
Grant Program:
Entrepreneurs' Programme - Accelerating Commercialisation
Grant Activity:
Commercialisation of single-dose biopolymer vaccine delivery platform
Purpose:
Capsular Technologies is the proprietor of a biopolymer-based vaccine encapsulation technology for the delivery of animal health therapeutics via a single-dose injection which enables sustained release of vaccine. This proven delivery platform will significantly improve productivity and animal health and welfare in the livestock industry. Accelerating Commercialisation support will be used to establish a pilot-scale production facility to supply biopolymer-based vaccines to the licensee to support preclinical and clinical trials, which will lead to the successful registration of the vaccine with APVMA and ultimately with sales of Australian-made vaccines.
GO ID:
GO Title:
Entrepreneurs' Programme - Accelerating Commercialisation
Internal Reference ID:
AC82280
Selection Process:
Open Competitive
Confidentiality - Contract:
No
Confidentiality - Outputs:
No
Grant Recipient Details
Recipient Name:
CAPSULAR TECHNOLOGIES PTY LTD
Recipient ABN:
67 615 605 742
Grant Recipient Location
Suburb:
HAWTHORN
Town/City:
HAWTHORN
Postcode:
3122
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
3122
Country:
AUSTRALIA